Medicines / Glenmark Pharmaceuticals / Mitinab
MitinabImatinib Mesylate
Mitinab is marketed by Glenmark Pharmaceuticals. 2 packs on NPPA's price list for July 2026, containing Imatinib Mesylate.
- Packs listed
- 2
- Lowest MRP
- ₹1,402
- Per unit
- ₹223.56 to ₹233.66
- Price-controlled packs
- 2 of 2
- Dosage forms
- 1
Packs and prices
- ₹6,707Mitinab 400 mg Tablet 30Imatinib Mesylate Tablet 400 mg · ₹223.56 per tablet · price-controlled, ceiling ₹204.41 per tablet
- ₹1,402Mitinab 400 mg Tablet 6Imatinib Mesylate Tablet 400 mg · ₹233.66 per tablet · price-controlled, ceiling ₹204.41 per tablet
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Imatinib Mesylate Tablet 400 mg
- ₹45.94/tabletAltanib Nova · 10 tabletAlkem Laboratories · MRP ₹459.38 · price-controlled, ceiling ₹204.41 per tablet
- ₹46.50/tabletMytinib · 10 tabletViatris · MRP ₹465.03 · price-controlled, ceiling ₹204.41 per tablet
- ₹50.60/tabletAdmin · 10 tabletSanatra Health Care · MRP ₹506.00 · price-controlled, ceiling ₹204.41 per tablet
- ₹94.43/tabletLevin(drl) · 10 tabletDr. Reddys Laboratories · MRP ₹944.26 · price-controlled, ceiling ₹204.41 per tablet
- ₹120.60/tabletChemotinib · 10 tabletNeon Laboratories · MRP ₹1,206 · price-controlled, ceiling ₹204.41 per tablet
- ₹175.87/tabletImatinib · 10 tabletSun Pharma Laboratories · MRP ₹1,759 · price-controlled, ceiling ₹204.41 per tablet
- ₹178.13/tabletMatiny · 10 tabletAureate Healthcare · MRP ₹1,781 · price-controlled, ceiling ₹204.41 per tablet
- ₹181.85/tabletImatib · 10 tabletCipla · MRP ₹1,818 · price-controlled, ceiling ₹204.41 per tablet
20 other brands of this composition on the price list; the 8 lowest per tablet are shown. All Imatinib Mesylate packs
The company
Glenmark Pharmaceuticals has 913 packs on the price list, and CDSCO has named it as the manufacturer of 15 failed batches since Feb 2018. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.